Objective To assess the efficacy and safety of catheter ablation (CA) compared with
antiarrhythmic drugs (AADs) as first-line treatment for symptomatic paroxysmal atrial …

Effective stroke prevention with oral anticoagulation (OAC) is the cornerstone of the
management of patients with atrial fibrillation. The use of OAC reduces the risk of stroke and …

AF has major clinical implications on patients' quality of life, morbidity with ischaemic stroke
and heart failure, and mortality when compared with the general population. 1 AF is the most …

Abstract Background The 4S‐AF scheme and the ABC pathway for integrated care have
been proposed to better characterize and treat patients with atrial fibrillation (AF). We aimed …

Background and purpose Prospectively collected data comparing the safety and
effectiveness of individual non-vitamin K antagonists (NOACs) are lacking. Our objective …

Background Effective stroke prevention with oral anticoagulants (OAC) is recommended for
some patients with atrial fibrillation (AF). We aimed to describe OAC use by geographical …

Background Patients with atrial fibrillation commonly have complex clinical backgrounds of
multimorbidity and polypharmacy. The Atrial Fibrillation Better Care (ABC) pathway has …

Aims Adherence to guideline-directed oral anticoagulation (OAC) in patients with atrial
fibrillation (AF) improves outcomes, but limited data are available from China. We evaluated …

Cardiovascular implantable electronic devices (CIEDs) are essential management options
for patients with brady-and tachyarrhythmias or heart failure with concomitant optimal …

Background Atrial fibrillation (AF) is a complex disease associated with comorbidities and
adverse outcomes. The Atrial fibrillation Better Care (ABC) pathway has been proposed to …